Radboud University Nijmegen Medical Centre

Department of Cognitive Neuroscience
Donders Institute for Brain, Cognition and Behaviour
Geert Grooteplein-Noord 21
6525 EZ Nijmegen, The Netherlands
Homepage

 

Project leader
Prof. Jan K. Buitelaar
Phone: +31-24-36-10750  or  +31-24-36-10655
Fax:       +31-24-35-41435
 
Project staff
Dr Cees Kan
Prof. Rutger Jan van der Gaag
Dr Jacqueline de Graaf
Dr George Pop

 

Description of the organization

The Radboud University Nijmegen Medical Centre (RUNMC) is a leading Dutch institute for medical research. The Department of Psychiatry and the Karakter Child and Adolescent Psychiatry University Centre (both headed by Professor Jan K Buitelaar) are specialized in clinical care and research in neuropsychiatric disorders such as ADHD, Conduct Disorder, Schizophrenia and Autism Spectrum Disorders. This research is embedded in two local research institutes, the Donders Institute for Brain, Cognition and Behaviour, and the Nijmegen Centre for Evidence‐Based Practice. As such, research into the efficacy and safety of medication treatment for psychiatric disorders in children and adolescents and adults is of a high priority.

The Nijmegen outpatient clinics have approximately 400 new child and adolescent ADHD patients and about 200 new adult ADHD patients per year. They have a database of more than 2000 children with ADHD, and 600 adults with ADHD. The clinical and research teams include a total of 30 child and adolescent psychiatrists, 15 adult psychiatrists, 20 senior psychologists, 5 post‐doctoral staff and 20 trainees.

 

Previous experience

RUNMC (Prof Jan K Buitelaar) has been involved in many international collaborations, including multisite international medication trials (Buitelaar et al 2007; Medori et al 2008; Reyes et al 2006) and NIH sponsored projects on the genetics of ADHD (International Multisite ADHD Genetics – IMAGE, R01MH62873 to Steve Faraone, P.I.) and on gene‐by environment interactions in an Autism Birth Cohort (UO1 NS 047537‐01 to Ian Lipkin, P.I.). Prof Jan Buitelaar has been Principle Investigator of several largescale national research projects, including a screening study for Autism Spectrum Disorder in over 30,000 infants. He is also the Principle Investigator of the Pediatric European Risperidone Study (PERS) which will be funded by FP7. RUNMC also has a great deal of expertise in the management and coordination of FP6 and FP7 Integrated Projects.

 

Profile of staff members

Jan K Buitelaar (MD, PhD) is a child and adolescent psychiatrist, and Professor of Psychiatry and Child and Adolescent Psychiatry. He is also the Head of the Department of Psychiatry at RUNMC and of the Karakter Child and Adolescent Psychiatry University Centre. He has been involved in numerous medication trials in children and adolescents with ADHD, Conduct Disorder and Autism Spectrum Disorder. Prof. Buitelaar is also Editor‐in‐Chief of the Journal of European Child and Adolescent Psychiatry. Furthermore, Prof. Buitelaar is active in genetic, brain imaging and cognitive studies, and has published over 280 peer‐reviewed papers.

Cees Kan (MD, PhD) is a psychiatrist and Director of the Outpatient Adult ADHD Clinic and is also involved in basic and applied research in adult ADHD.

Rutger Jan van der Gaag (MD, PhD) is a child and adolescent psychiatrist and Professor of Clinical Child and Adolescent Psychiatry. His areas of expertise include medication research in ADHD, Oppositional Defiant Disorder and Conduct Disorder. He is Director of the Outpatient and Inpatient Units for Child Psychiatry.

Jacqueline de Graaf (MD, PhD) is a specialist in internal medicine, and in particular in vascular medicine. She is an expert in vascular reactivity measurements.

George Pop (MD, PhD) is a cardiologist with expertise in 24 hour blood pressure measurements and echocardiography.

Leonie Hennissen (Msc) is a research assistent.

Main tasks in the project

This partner is responsible for WP8 (Cardiovascular Safety). In addition, RUNMC will participate and contribute to WP2, WP3 and WP4.

News

The second ADDUCE Newsletter is available!
Read more about the 2 main ADDUCE studies:

  • WP3: prospective open-label methylphenidate
    pharmacovigilance study
  • WP8: long-term cardiovascular effects of methylphenidate use

and much more in the ADDUCE Newsletter 2, February 2013

Events

21 - 24 May 2014:

3rd EUNETHYDIS International Conference on ADHD, Istanbul Turkey
ADHD and related disorders

3 - 6 OCTOBER 2013:

23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders

4 & 5 JUNE 2013:

ADDUCE Consortium meeting, Milan Italy

6 - 9 JUNE 2013:            

4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy

 6 & 7 JUNE 2012:            

ADDUCE Consortium meeting, Cagliari - Italy

23 MAY 2012:

Eunethydis, 2nd International ADHD Conference

Homepage Eunethydis Conference 2012